News Ipsen

Equities

IPN

FR0010259150

Real-time Euronext Paris Other stock markets 07:14:35 2024-05-06 am EDT			5-day change	1st Jan Change
114.5 ^EUR	0.00%		+1.78%	+6.12%

May. 02	Ipsen Announces Executive Changes	CI
May. 02	Ipsen: new President for North America	CF

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Ipsen Announces Executive Changes	May. 02	CI
Ipsen: new President for North America	May. 02	CF
Ipsen appoints Keira Driansky as EVP, President of North America	May. 02	GL
IPSEN : Better-than-expected Q1; guidance unchanged	Apr. 24
Ipsen : Q1 2024 – sales presentation (1.17 MB)	Apr. 24	PU
Transcript : Ipsen S.A., Q1 2024 Sales/ Trading Statement Call, Apr 24, 2024	Apr. 24
Ipsen: sales up 11% in Q1	Apr. 24	CF
Ipsen : Q1 2024 – sales announcement (228.28 KB)	Apr. 24	PU
Ipsen : Q1 2024 – highlights (288.70 KB)	Apr. 24	PU
Ipsen delivers strong sales in the first quarter of 2024, driven by growth platforms & new medicines, and confirms its full-year guidance	Apr. 24	GL
Ipsen delivers strong sales in the first quarter of 2024, driven by growth platforms & new medicines, and confirms its full-year guidance	Apr. 24	AQ
Ipsen Teams Up with Skyhawk Therapeutics on Study of RNA Modulator for Rare Neurological Diseases	Apr. 22	MT
Ipsen: collaboration agreement with Skyhawk	Apr. 22	CF
Ipsen and Skyhawk Therapeutics announce RNA targeting research collaboration in rare neurological diseases	Apr. 22	GL
Ipsen and Skyhawk Therapeutics Announces RNA Targeting Research Collaboration in Rare Neurological Diseases	Apr. 22	CI
Ipsen : 2023 Universal Registration Document	Apr. 18	PU
Ipsen publishes its 2023 Universal Registration Document	Apr. 17	GL
Ipsen publishes its 2023 Universal Registration Document	Apr. 17	AQ
Ipsen: Parvus AM Europe Ltd exceeds 5% of voting rights	Apr. 15	CF
Marengo Therapeutics Announces First Drug Candidate Nomination from Oncology Collaboration with Ipsen	Apr. 03	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

IPSEN : Better-than-expected Q1; guidance unchanged

April 24, 2024 at 10:50 am EDT